Neuraxis, INC(NRXS)— Stock Profile, AI Score & Financials

Healthcare · NYSE · AI-powered stock analysis, 32-signal quality score, SEC EDGAR financials, and institutional holdings. Updated 2026-06-30.

Neuraxis, INC (NRXS) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. 13F Pro's AI-powered ranking engine scores NRXS at 32.1/100 on a 32-signal composite quality model, placing it at rank #2,435 of 2,962 stocks — the bottom half of the AI-ranked universe. Based on the latest XBRL financial filings (Q2 2026), Neuraxis, INC reports quarterly revenue of $1.9M, net income of $-2.1M. Top institutional holders of NRXS by reported 13-F value include AIGH Capital Management, Rosalind Advisors, VANGUARD CAPITAL MANAGEMENT, based on the most recent SEC filings. NRXS trades on the NYSE exchange and files with the SEC under CIK 1933567. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate NRXS daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Neuraxis, INC directly from SEC EDGAR.